Improving the Patient Experience in Cancer

As the healthcare industry becomes more saturated with big data, the search continues for data that can inform decisions that positively impact the experience and outcomes of patients with cancer. Big data, defined by large datasets with substantial numbers of patients and a wide array of clinical and claims data, can support certain types of statistical analyses. However, these datasets are limited because their datapoints are discrete, providing only sequential snapshots of a patient’s health status, without a more continuous assessment of the patient’s experience on treatment, which can only originate from the patients themselves.

Our Fierce webinar is geared to individuals across the life science value chain who see the benefit of patient-reported outcomes (PRO) in cancer care, including HEOR, Patient Centered Outcomes and Real World Data experts. Ethan Basch, MD (a leading PRO researcher and oncologist), Stacie Hudgens (CEO of COS, a Carevive partner with expertise in PRO research and analysis) and Carevive experts, will illustrate how life science stakeholders can use these data to answer important questions about the experience of real world patients with cancer.​

In this webinar we will accomplish the following:​

Explore – Why do we measure patient experience?​
Evaluate – How do we measure it?​
Observe – What does the experience of a patient with cancer look like?​
Implement – What can different healthcare stakeholders do with our data to improve patient care across the life science value chain?

Recent Episodes

With the healthcare landscape seeing many evolving changes, employee engagement is no longer just a buzzword — it’s now a business imperative. Amid rising turnover and persistent staffing shortages, organizations are under pressure to build resilient, engaged teams. According to Gallup, 70% of the variance in team engagement is tied to one factor: the…

Pharmaceutical manufacturers are under increasing pressure to deliver sterile, high-quality medicines in smaller batches and faster cycles. As pharma manufacturing evolves, regulatory demands have intensified, especially following the 2023 revision of EU GMP Annex I, which places new emphasis on contamination control strategies, improved traceability, and minimizing human intervention throughout production. According to American…

In this special episode of Care Anywhere: The Global Health Workforce Podcast, host Lea Sims welcomes two passionate advocates for ethical nurse recruitment: Jocelyn Musni, Chief Clinical Officer at Alere Care Solutions and 2025 recipient of the Daisy Award for Ethical Nurse Recruitment, and Coleen Santa Anna, Managing Owner and CEO of Alere. Together,…